// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

PRIORITIZATION OF RENAL CANCER QUALITY INDICATORS USING VARIANCE DECOMPOSITION AND MEDIATION ANALYSIS METHODS

Keith Lawson - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

EXPLOITING NOVEL THERAPEUTIC TARGETS TO BLOCK METASTASIS OF CLEAR CELL RENAL CELL CARCINOMA (RCC)

Jan Rudzinski - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Clear cell renal carcinoma

N/A

UROLOGICAL DISEASE AS A BASIS FOR MIRACLES IN THE CANONIZATION PROCESS OF THE ROMAN CATHOLIC CHURCH

Naji Touma - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IMPACT OF PUTATIVE CHEMOPREVENTATIVE AGENTS ON PROSTATE CANCER DIAGNOSIS

Hanan Goldberg - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Thiazolidinedione

IMPROVING THE SAFETY AND EFFICACY OF PHOTODYNAMIC THERAPY FOR NMIBC– INTRAVESICAL RUTHENIUM (II)-PHOTOSENSITIZER AND LIGHT DOSIMETRY IN A PHASE 1B CLINICAL TRAIL

Lothar Lilge - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

TLD1433

FUSOGENIC LIPOSOMES AS A NOVEL NANOTHERAPY AGAINST METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Jan Rudzinski - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Clear cell renal carcinoma

N/A

A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION

Thomas Hermanns - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

N/A

INVESTIGATING THE IMPACT OF A LOWER TESTOSTERONE THRESHOLD ON CASTRATION-RESISTANT PROGRESSION IN PATIENTS ON CONTINUOUS ANDROGEN DEPRIVATION THERAPY

Maylynn Ding - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Androgen Tear

DEPRESSION IN PROSTATE CANCER PATIENTS STARTING ANDROGEN DEPRIVATION THERAPY

Gagan Fervaha - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Androgen Tear

MOLECULAR SUBTYPING REVEALS LUMINAL BLADDER TUMORS HAVE LOWER RATES OF PATHOLOGICAL UPSTAGING AT RADICAL CYSTECTOMY

Yair Lotan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

N/A

THE PROSTATIC URETHRAL LIFT (UROLIFT) VERSUS THE THERMAL WATER VAPOR ABLATION (REZÅ«M) FOR MINIMALLY INVASIVE TREATMENT OF BPH: A COMPARISON OF IMPROVEMENTS AND DURABILITY IN 3-YEAR CLINICAL OUTCOMES

Shaun Shepherd - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE USE OF PROSTATE AND BLADDER-SPECIFIC MEDICATIONS AFTER TRANSURETHRAL PROSTATECTOMY

Jeffrey Campbell - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

CHARACTERIZATION OF CERVIX INNERVATION: RELEVANCE TO LOOP ELECTROSURGICAL EXCISION PROCEDURES

Madeline Monaghan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

FEMALE PERIURETHRAL TISSUE INNERVATION STUDIES: MID-URETHRAL SLING SURGERIES MAY RESULT IN SEXUAL DYSFUNCTION

Olivia Giovannetti - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Sexual dysfunction

N/A

EVALUATION OF VULVAR HEALTH FROM PHOTOGRAPHS

Irwin Goldstein - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HIGH RESOLUTION 29 MHZ MICRO-ULTRASOUND IN THE DIAGNOSIS OF PRIMARY AND RECURRENT PROSTATE CANCER

Laurence Klotz - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL COMPARING NOVEL FIRST GENERATION HIGH-RESOLUTION MICRO-ULTRASOUND WITH CONVENTIONAL FREQUENCY ULTRASOUND FOR TRANSRECTAL PROSTATE BIOPSY

Christian Pavlovich - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

DO ELDERLY MEN (>75) HARBOR MORE AGGRESSIVE PROSTATE CANCER? COMPARISON OF DECIPHER AND PAM50 TESTS AMONG DIFFERENT AGE GROUPS

Hanan Goldberg - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

IMPACT OF COMORBIDITY ON LONG-TERM OUTCOMES IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY COMPARED TO PARTIAL NEPHRECTOMY: A POPULATION-BASED RETROSPECTIVE COHORT STUDY

Harmenjit Brar - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

FLUOROSCOPIC TARGETING OF RENAL CALCULI DURING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY USING A MACHINE LEARNING ALGORITHM

Rohit Singla - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Nephrolithiasis, calcium oxalate

N/A

Copyright © 2026. QuantiNova All rights reserved